OMEROS CORP Prepaid Expense and Other Assets, Current
OMEROS CORP (OMER) had Prepaid Expense and Other Assets, Current of $5.54 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $5.54M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $7.35M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $7.59M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $3.76M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.54M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $7.35M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.59M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.76M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.41M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $7.47M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $7.17M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $6.13M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $6.27M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $13.46M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $8.58M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $4.92M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $7.00M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $6.71M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $6.30M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $5.98M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $11.89M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $7.62M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $8.22M 10-K · filed 2023-03-13 | $8.15M 10-K · filed 2022-03-01 |
| 2021-09-30 | $6.37M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $5.93M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $5.98M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $10.46M 10-K · filed 2022-03-01 | $11.14M 10-K · filed 2021-03-01 |
| 2020-09-30 | $3.54M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $5.17M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.30M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.63M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $5.35M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $4.40M 10-Q · filed 2019-08-08 | |
| 2018-12-31 | $6.46M 10-K · filed 2020-03-02 | |
| 2013-12-31 | $337.00K 10-K · filed 2014-03-13 | |
| 2013-09-30 | $391.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $494.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $494.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $416.00K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $341.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $485.00K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $438.00K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $502.00K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $210.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $333.00K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $282.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |